Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ISRCTN14937154) titled 'The fixed-dose combination of fenofibrate with atorvastatin effectively reduces Non-HDL Cholesterol and is superior to atorvastatin or fenofibrate alone' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Laboratorios Senosiain S.A. de C.V.
Condition:
Reduction of cardiovascular risk in adult patients with mixed dyslipidemia
Circulatory System
Intervention:
Eligible participants were randomly assigned in a 1:1:1 ratio to one of three treatment groups for 12 weeks...